The future directions of artificial intelligence in the biological benefit-dominated diagnosis and treatment of pancreatic cancer
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 1
Abstract
Pancreatic cancer is a high malignant tumor with insidious onset, early metastasis, and extremely poor prognosis. How to improve the early diagnosis and the prognosis of the patients is the current research focus. Although traditional surgical resection may improve the prognosis of some patients, the long-term effect is still poor. Biological benefit is the new mode of pancreatic cancer treatment, and it is crucial to do the whole process monitoring, precisely make the treatment plan and predict the effect under this mode. Artificial intelligence technology, with its powerful data processing and image recognition functions and high learning efficiency, can help to build relatively perfect prediction models with the cooperation of multidisciplinary experts, assist clinicians to make optimal plans, and make the pancreatic cancer patients benefit from precision medicine and individualized therapy.
Authors and Affiliations
Zhong QI, Ying XING, Shi CHENG
Keywords
Related Articles
- EP ID EP750941
- DOI 10.16139/j.1007-9610.2024.01.02
- Views 18
- Downloads 1
<![CDATA[Optimal timing of surgery for locally advance rectal cancer: how we choose]]>
<![CDATA[Locally advanced rectal cancer (LARC) is associated with a high risk of local recurrence and distant metastasis, making it difficult to be cured by surgery alone. Neoadjuvant chemoradiotherapy followed by surger...
Stage on development of pathophysiology of gallbladder stone and personalized diagnosis and treatment
Gallbladder stone (GS) is a common disease. There are no obvious symptoms at early stage for the patient with GS. Obstruction will cause acute cholecystitis. Secondary obstructive cholangitis of GS, biliary pancreatitis,...
Perioperative intensive care for cardiac surgery patients
The rapid development of perioperative intensive care in cardiac surgery has greatly improved the prognosis for patients undergoing major cardiovascular surgery. In the field of hemodynamics, besides traditional methods,...
Critical care medicine and safety management of high-risk surgical patients
At present, although the mortality of most patients undergoing major surgery is very low, the increase of so-called high-risk surgery patients with high risk of postoperative complications and death brings new challenges...
Chinese interpretation of European Neuroendocrine Tumour Society 2023 guidance for nonfunctioning pancreatic neuroendocrine tumours
This ENETS guidance for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET), which published on Journal of Neuroendocrinology (2023), has been developed by a multidisciplinary working group,...